BTAI CIK: 1720893

BioXcel Therapeutics, Inc.

  • United States
  • Healthcare
  • Drug Manufacturers - Specialty & Generic
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−82.2
FY22:
−135
FY23:
−155
FY24:
−72.0
FY25:
−57.6
Change from FY21 to FY25
millions USD
FY21:
−0.45
FY22:
−0.14
FY23:
−0.02
FY24:
0
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
102
FY22:
96.2
FY23:
26.5
FY24:
36.7
FY25:
56.5
millions USD
FY21:
19.8
FY22:
−39.2
FY23:
−129
FY24:
−35.4
FY25:
−1.10
(positive)
Change from FY21 to FY25
millions USD
FY21:
−82.6
FY22:
−135
FY23:
−155
FY24:
−72.0
FY25:
−57.6

All amounts in millions USD Data sources:SEC EDGARTwelve Data